175 related articles for article (PubMed ID: 3985585)
1. Cerebrospinal fluid acetylcholinesterase activity in senile dementia of the Alzheimer type.
Tune L; Gucker S; Folstein M; Oshida L; Coyle JT
Ann Neurol; 1985 Jan; 17(1):46-8. PubMed ID: 3985585
[TBL] [Abstract][Full Text] [Related]
2. [Acetylcholinesterase activity in CSF in senile dementia of Alzheimer type, vascular dementia, and Parkinson's disease].
Yoshinaga J; Sasaki T; Ideshita H; Hikiji A; Kuwaki T
Rinsho Shinkeigaku; 1989 Mar; 29(3):376-8. PubMed ID: 2752667
[TBL] [Abstract][Full Text] [Related]
3. Cerebrospinal fluid cholinesterases in aging and in dementia of the Alzheimer type.
Atack JR; May C; Kaye JA; Kay AD; Rapoport SI
Ann Neurol; 1988 Feb; 23(2):161-7. PubMed ID: 3377438
[TBL] [Abstract][Full Text] [Related]
4. Acetylcholinesterase activity in CSF in schizophrenia, depression, Alzheimer's disease and normals.
Deutsch SI; Mohs RC; Levy MI; Rothpearl AB; Stockton D; Horvath T; Coco A; Davis KL
Biol Psychiatry; 1983 Dec; 18(12):1363-73. PubMed ID: 6661467
[TBL] [Abstract][Full Text] [Related]
5. Cerebrospinal fluid neurochemistry in the myoclonic subtype of Alzheimer's disease.
Kaye JA; May C; Atack JR; Daly E; Sweeney DL; Beal MF; Kaufman S; Milstien S; Friedland RP; Rapoport SI
Ann Neurol; 1988 Nov; 24(5):647-50. PubMed ID: 2462403
[TBL] [Abstract][Full Text] [Related]
6. Glycosylation of acetylcholinesterase and butyrylcholinesterase changes as a function of the duration of Alzheimer's disease.
Sáez-Valero J; Fodero LR; Sjögren M; Andreasen N; Amici S; Gallai V; Vanderstichele H; Vanmechelen E; Parnetti L; Blennow K; Small DH
J Neurosci Res; 2003 May; 72(4):520-6. PubMed ID: 12704813
[TBL] [Abstract][Full Text] [Related]
7. Cerebrospinal fluid levels of biomarkers and activity of acetylcholinesterase (AChE) and butyrylcholinesterase in AD patients before and after treatment with different AChE inhibitors.
Parnetti L; Amici S; Lanari A; Romani C; Antognelli C; Andreasen N; Minthon L; Davidsson P; Pottel H; Blennow K; Gallai V
Neurol Sci; 2002 Sep; 23 Suppl 2():S95-6. PubMed ID: 12548360
[TBL] [Abstract][Full Text] [Related]
8. Association between acetylcholinesterase and beta-amyloid peptide in Alzheimer's cerebrospinal fluid.
García-Ayllón MS; Silveyra MX; Sáez-Valero J
Chem Biol Interact; 2008 Sep; 175(1-3):209-15. PubMed ID: 18554581
[TBL] [Abstract][Full Text] [Related]
9. Acetylcholinesterase activity in cerebrospinal fluid of patients with Alzheimer's disease and senile dementia.
Nakano S; Kato T; Nakamura S; Kameyama M
J Neurol Sci; 1986 Sep; 75(2):213-23. PubMed ID: 3760912
[TBL] [Abstract][Full Text] [Related]
10. Cerebrospinal fluid acetylcholinesterase changes after treatment with donepezil in patients with Alzheimer's disease.
García-Ayllón MS; Silveyra MX; Andreasen N; Brimijoin S; Blennow K; Sáez-Valero J
J Neurochem; 2007 Jun; 101(6):1701-11. PubMed ID: 17326766
[TBL] [Abstract][Full Text] [Related]
11. Acetylcholinesterase and butyrylcholinesterase activities in cerebrospinal fluid from different levels of the neuraxis of patients with dementia of the Alzheimer type.
Appleyard ME; McDonald B
J Neurol Neurosurg Psychiatry; 1992 Nov; 55(11):1074-8. PubMed ID: 1469405
[TBL] [Abstract][Full Text] [Related]
12. Changes in CSF acetyl- and butyrylcholinesterase activity after long-term treatment with AChE inhibitors in Alzheimer's disease.
Parnetti L; Chiasserini D; Andreasson U; Ohlson M; Hüls C; Zetterberg H; Minthon L; Wallin AK; Andreasen N; Talesa VN; Blennow K
Acta Neurol Scand; 2011 Aug; 124(2):122-9. PubMed ID: 20880294
[TBL] [Abstract][Full Text] [Related]
13. Cholinesterase activities in cerebrospinal fluid of patients with senile dementia of Alzheimer type.
Appleyard ME; Smith AD; Berman P; Wilcock GK; Esiri MM; Neary D; Bowen DM
Brain; 1987 Oct; 110 ( Pt 5)():1309-22. PubMed ID: 3676702
[TBL] [Abstract][Full Text] [Related]
14. Laboratory examinations correlated with severity of dementia.
Oishi M; Mochizuki Y; Yoshihashi H; Takasu T; Nakano E
Ann Clin Lab Sci; 1996; 26(4):340-5. PubMed ID: 8800434
[TBL] [Abstract][Full Text] [Related]
15. Plasma and cerebrospinal fluid alpha1-antichymotrypsin levels in Alzheimer's disease: correlation with cognitive impairment.
DeKosky ST; Ikonomovic MD; Wang X; Farlow M; Wisniewski S; Lopez OL; Becker JT; Saxton J; Klunk WE; Sweet R; Kaufer DI; Kamboh MI
Ann Neurol; 2003 Jan; 53(1):81-90. PubMed ID: 12509851
[TBL] [Abstract][Full Text] [Related]
16. Cerebrospinal fluid biomarkers in Parkinson's disease with dementia and dementia with Lewy bodies.
Parnetti L; Tiraboschi P; Lanari A; Peducci M; Padiglioni C; D'Amore C; Pierguidi L; Tambasco N; Rossi A; Calabresi P
Biol Psychiatry; 2008 Nov; 64(10):850-5. PubMed ID: 18395699
[TBL] [Abstract][Full Text] [Related]
17. Re-evaluation of cerebrospinal fluid angiotensin-converting enzyme activity in patients with 'probable' Alzheimer's disease.
Konings CH; Kuiper MA; Scheltens P; Grijpma AM; van Pelt W; Wolters EC
Eur J Clin Chem Clin Biochem; 1993 Aug; 31(8):495-7. PubMed ID: 8218581
[TBL] [Abstract][Full Text] [Related]
18. CSF APPs alpha and phosphorylated tau protein levels in mild cognitive impairment and dementia of Alzheimer's type.
Fellgiebel A; Kojro E; Müller MJ; Scheurich A; Schmidt LG; Fahrenholz F
J Geriatr Psychiatry Neurol; 2009 Mar; 22(1):3-9. PubMed ID: 19073834
[TBL] [Abstract][Full Text] [Related]
19. Altered glycosylation of acetylcholinesterase in Creutzfeldt-Jakob disease.
Silveyra MX; Cuadrado-Corrales N; Marcos A; Barquero MS; Rábano A; Calero M; Sáez-Valero J
J Neurochem; 2006 Jan; 96(1):97-104. PubMed ID: 16277609
[TBL] [Abstract][Full Text] [Related]
20. Cerebrospinal fluid levels of angiotensin-converting enzyme, acetylcholinesterase, and dopamine metabolites in dementia associated with Alzheimer's disease and Parkinson's disease: a correlative study.
Zubenko GS; Marquis JK; Volicer L; Direnfeld LK; Langlais PJ; Nixon RA
Biol Psychiatry; 1986 Dec; 21(14):1365-81. PubMed ID: 3024746
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
